RIM
ONC

Redpoint Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Redpoint Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,242
Closed -$201K – 615
2022
Q2 		$201K Hold
1,242
– – 0.02% 587
2022
Q1 		$234K Hold
1,242
– – 0.02% 594
2021
Q4 		$336K Sell
1,242
-309
-20% -$104K 0.03% 552
2021
Q3 		$563K Hold
1,551
– – 0.05% 416
2021
Q2 		$532K Buy
+1,551
New +$514K 0.04% 436
2021
Q1 		– Sell
-1,234
Closed -$319K – 669
2020
Q4 		$319K Buy
+1,234
New +$340K 0.03% 468

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Redpoint Investment Management's ONC Position: Q3 2022 in Review

Redpoint Investment Management sold out of BeOne Medicines Ltd (ONC) in Q3 2022, closing a stake of 1,242 shares — an estimated $201K sold.

Redpoint Investment Management first reported a position in ONC in Q4 2020 and held it in 6 quarters. The position peaked at $563K in Q3 2021. 222 funds tracked by Wall St. Rank hold ONC as of Q3 2022.

  • Redpoint Investment Management reported no remaining BeOne Medicines Ltd position as of Q3 2022 after selling out during the quarter.
  • Redpoint Investment Management sold 1,242 BeOne Medicines Ltd shares in Q3 2022, an estimated $201K.
  • Redpoint Investment Management first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 6 quarters.
  • Redpoint Investment Management's BeOne Medicines Ltd position peaked at $563K in Q3 2021.
  • 222 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.